Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dropbox Inc (DBX) vs Cassava Sciences Inc (FLNA) Price & Performance

Dropbox IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Dropbox Inc vs Cassava Sciences Inc — how do they compare? Dropbox Inc trades at $29.72 (market cap $6.99B), while Cassava Sciences Inc trades at $1.09 (market cap $52.66M). The key difference: Dropbox Inc is far larger — about 132.7× Cassava Sciences Inc's market cap, and Dropbox Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

DBXFLNA
Market Cap
$6.99B$52.66M
Sector
TechnologyHealth
52-Week High
$32.17$4.64
52-Week Low
$22.06$1.09
Enterprise Value
$9.71B-$33.92M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dropbox Inc

Dropbox (DBX) trades at $29.58, up 1.34% on the day, near the analyst consensus price target of $30. The stock shows a bullish technical trend with strong moving average signals, though RSI levels indicate potential overbought conditions. Fundamentally, the company maintains robust profitability with a net income margin of 18.71% and has beaten earnings estimates for three consecutive quarters. Recent news highlights a new $900 million stock repurchase program and a CEO transition plan announced in May 2026.

The outlook is balanced with solid fundamentals and shareholder returns offset by high debt levels and mixed analyst sentiment. Investment appeal lies in consistent earnings beats and capital return initiatives, but risks include elevated leverage and competitive pressures in cloud storage. The stock presents a moderate opportunity with cautious optimism warranted given its valuation near target prices.

Cassava Sciences Inc

FLNA trades at $1.15, down 2.54% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company continues to report losses, with a net income of -$90.97M in 2025 and negative cash flow, though it has beaten EPS estimates for the last three quarters. Recent news highlights ongoing development in its TSC-related epilepsy therapies.

Despite consistent earnings beats, FLNA's negative profitability and cash burn pose significant risks. Analyst sentiment is positive with a 66.7% buy rating, but the stock's outlook depends heavily on clinical success and future funding. Investors should weigh the high-risk, high-reward nature of this biotech play.

Returns comparison

Trailing returns across standard periods

About Dropbox Inc

Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.

Read more on DBX

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA